These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149 [TBL] [Abstract][Full Text] [Related]
33. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease. Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409 [TBL] [Abstract][Full Text] [Related]
34. Aortic Stenosis with Severe Tricuspid Regurgitation: Comparative Study between Conservative Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Combined With Tricuspid Repair. Rozenbaum Z; Granot Y; Steinvil A; Banai S; Finkelstein A; Ben-Gal Y; Keren G; Topilsky Y J Am Soc Echocardiogr; 2018 Oct; 31(10):1101-1108. PubMed ID: 30107957 [TBL] [Abstract][Full Text] [Related]
35. [Midterm outcome comparison between patients with bicuspid or tricuspid aortic stenosis undergoing transcatheter aortic valve replacement]. Li J; Sun YH; Li G; Fu M; Mo YJ; Zheng SN; Dong HJ; Fan RX; Luo JF Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):759-764. PubMed ID: 32957759 [No Abstract] [Full Text] [Related]
36. Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Halim SA; Edwards FH; Dai D; Li Z; Mack MJ; Holmes DR; Tuzcu EM; Thourani VH; Harrison JK; Brennan JM Circulation; 2020 Mar; 141(13):1071-1079. PubMed ID: 32098500 [TBL] [Abstract][Full Text] [Related]
38. Mitral Regurgitation After Transcatheter Aortic Valve Replacement: Prognosis, Imaging Predictors, and Potential Management. Cortés C; Amat-Santos IJ; Nombela-Franco L; Muñoz-Garcia AJ; Gutiérrez-Ibanes E; De La Torre Hernandez JM; Córdoba-Soriano JG; Jimenez-Quevedo P; Hernández-García JM; Gonzalez-Mansilla A; Ruano J; Jimenez-Mazuecos J; Castrodeza J; Tobar J; Islas F; Revilla A; Puri R; Puerto A; Gómez I; Rodés-Cabau J; San Román JA JACC Cardiovasc Interv; 2016 Aug; 9(15):1603-14. PubMed ID: 27491611 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience. Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204 [TBL] [Abstract][Full Text] [Related]
40. Optimal pre-TAVR annulus sizing in patients with bicuspid aortic valve: area-derived perimeter by CT is the best-correlated measure with intraoperative sizing. Wang Y; Wang M; Song G; Wang W; Lv B; Wang H; Wu Y Eur Radiol; 2019 Jan; 29(1):259-269. PubMed ID: 29926206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]